Comparison Chart Vertex Pharmaceuticals Incorporated

VRTX

US92532F1003

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	VERTEX PHARMACEUTICALS INCORPORATED	Other Pharmaceuticals	+6.03%	+7.47%	+16.47%	+14.89%	+163.31%	134B

07-02	Vertex Pharmaceuticals Incorporated Receives Us Fda Approval for Expanded Use of Casgevy for Treatment of People Ages 2 Years and Older with Sickle Cell Disease or Transfusion-Dependent Beta Thalassemia	CI
07-02	Vertex Pharmaceuticals Says FDA Approves Expanded Use of Casgevy in Younger Children With Blood Disorders	MT

Market Closed - Nasdaq Other stock markets 21:00:00 02/07/2026 BST			5-day change	1st Jan Change
528.04 ^USD	+6.03%		+7.47%	+16.47%

Comparison Chart Vertex Pharmaceuticals Incorporated

Stocks

VRTX

US92532F1003

Pharmaceuticals

Compared values